1-3 of 3
Elias Campo, PhD
Close
Sort by
Journal Articles

The Novel HSP90 Inhibitor IPI-504 Synergizes with Bortezomib in Mantle Cell Lymphoma Cells by Targeting Both NF-kappaB Signaling and Unfolded Protein Response and Leading to Increased Mitochondrial Apoptosis.

Gael Roue, PhD, Patricia Perez-Galan, PhD, Monica Lopez-Guerra, BS, Neus Villamor, PhD, MD, Elias Campo, PhD, MD, Dolors Colomer, PhD
Journal: Blood
Blood (2007) 110 (11): 1601.
https://doi.org/10.1182/blood.V110.11.1601.1601
Published: 2007
Journal Articles

Gene Expression Signature of Acute Myeloid Leukemia (AML) with T(8;16)(P11;P13) and MYST3-CREBBP Rearrangement: A Microarray Study Validated by Multiple Real-Time PCR.

Mireia Camos, MD, Jordi Esteve, MD, Dolors Colomer, PhD, Pedro Jares, PhD, Maria Rozman, MD, Neus Villamor, MD, Dolors Costa, PhD, Ana Carrio, PhD, Josep F. Nomdedeu, MD, Emili Montserrat, MD, Elias Campo, PhD
Journal: Blood
Blood (2005) 106 (11): 3009.
https://doi.org/10.1182/blood.V106.11.3009.3009
Published: 2005
Journal Articles

The Small Molecule Pan-Bcl-2 Inhibitor GX15-070 Induces Apoptosis In Vitro in Mantle Cell Lymphoma (MCL) Cells and Exhibits a Synergistic Effect in Combination with the Proteasome Inhibitor Bortezomib.

Patricia Perez Galan, PhD, Gael Roue, PhD, Neus Villamor, PhD, MD, Elias Campo, PhD, MD, Dolors Colomer, PhD
Journal: Blood
Blood (2005) 106 (11): 1490.
https://doi.org/10.1182/blood.V106.11.1490.1490
Published: 2005